16
Participants
Start Date
November 30, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
February 28, 2027
T-Control® (experimental)
Patients will receive intravesical therapy (1-2 hours) through T-Control®, a new Foley-type silicone catheter with an integrated fluid-control valve into the catheter's distal end, which has three positions.
Folysil® (control)
Patients will receive intravesical therapy (1-2 hours) through Folysil® Silicone catheter (Coloplast), the usual clinical practice in the participating center.
Rethink Medical SL
INDUSTRY